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ABSTRACT
Spliceosome formation is initiated by the recognition
of the 50 splice site through formation of an RNA
duplex between the 50 splice site and U1 snRNA.
We have previously shown that RNA duplex format-
ion between U1 snRNA and the 50 splice site can pro-
tect pre-mRNAs from degradation prior to splicing.
This initial RNA duplex must be disrupted to expose
the 50 splice site sequence for base pairing with U6
snRNA and to form the active spliceosome. Here, we
investigated whether hyperstabilization of the U1
snRNA/50 splice site duplex interferes with splicing
efficiency in human cell lines or nuclear extracts.
Unlike observations in Saccharomyces cerevisiae,
we demonstrate that an extended U1 snRNA/50 splice
siteinteractiondoesnotdecreasesplicingefficiency,
but rather increases 50 splice site recognition and
exon inclusion. However, low complementarity of
the 50 splice site to U1 snRNA significantly increases
exon skipping and RNA degradation. Although the
splicing mechanisms are conserved between
human and S.cerevisiae, these results demonstrate
that distinct differences exist in the activation of the
spliceosome.
INTRODUCTION
A critical step in splicing is the nucleotide-speciﬁc recognition
of the exon and intron boundaries. For coding exons, this
guarantees maintenance of the open reading frame, for
non-coding exons it preserves cis-acting sequences that can
inﬂuence the properties of the mRNA, e.g. their stability (1,2).
Thus, it is not surprising that 50 splice site recognition seems
to be subjected to a proofreading mechanism in which the
50 splice site must be consecutively recognized by two dif-
ferent snRNAs. Initially, an RNA duplex is formed between
the 50 splice site and U1 snRNA, which is primarily thought
to promote the association of a U2 snRNP complex with
the branchpoint region (3) through the activities of the
DExD/H family RNA-dependent ATPase hPrp5 (4). However,
in vitro binding of the U2 snRNP to the branchpoint region
can occur independent of U1 snRNP binding to the 50 splice
site (5).
Subsequent to U2 snRNP binding, the tri-snRNP complex
consisting of U4/U6·U5 snRNP carries out its role within the
inactive spliceosome. As part of this tri-snRNP complex, the
U6 snRNA is associated with U4 snRNA by two RNA helices,
which must be unwound prior to base pairing between the 50
splice site and U6 snRNA (6). Because the U6 snRNA and U1
snRNA binding sites with the 50 splice site are mutually exclu-
sive, the initial RNA duplex between the 50 splice site and the
U1 snRNA must be disrupted prior to forming the active
spliceosome (7). The rearrangements between the pre-
mRNA and snRNAs are catalyzed by a large family of con-
served, ATP-dependent proteins, termed the DExH/D box
helicases (8). The U1 to U6 snRNA transition at the 50 splice
site is a dynamic process, which involves multiple RNA
annealing and dissociation activities. The elegant work by
Staley and Guthrie (9) demonstrated that ATP and the
DEAD Box Protein Prp28p are required for U1 destabilization
in yeast. Thus, it was reasonable to assume that an extended
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doi:10.1093/nar/gki824interaction between U1 snRNA and the 50 splice site interfered
with the subsequent and mutually exclusive association of U6
snRNA with the 50 splice site. Indeed, Staley and Guthrie (9)
demonstrated that hyperstabilization of the U1 snRNA/50
splice site interaction by extending base pairing between
U1 and the 50 splice site can lead to temperature-sensitive
splicing repression in yeast. The human homolog of
Prp28p, a U5 snRNP speciﬁc 100 kDa protein (U5-100K),
has also been identiﬁed (10).
The strength of the U1 snRNA/50 splice site interaction has
also been implicated in the regulation of alternative splicing
pattern and transcript stabilization. For example, during the
early phase of HIV-1 replication the two essential viral pro-
teins Tat and Rev are translated from multiple spliced viral
transcripts. However, during the late phase of the viral life
cycle, removal of the intron between the ﬁrst and second
codingexons oftatandrevhastoberestrainedsinceitencodes
part of the glycoprotein. Thus, glycoprotein expression is only
possible if splicing is inefﬁcient enough to allow Rev-
mediated nuclear export of the glycoprotein mRNA. We
have previously shown that U1 snRNA binding at HIV-1
50 splice site #4 protects the unstable glycoprotein pre-
mRNA against degradation, independent of splicing (11).
The formation of the stable RNA duplex between U1
snRNA and the 50 splice site allowed efﬁcient glycoprotein
expression because the splicing efﬁciency of this tat and
rev intron was impaired by an inefﬁcient 30 splice site
(12,13) and its associated splicing silencer ESS3 [(14–19)
and S. Kammler and H. Schaal, unpublished data].
Although numerous examples are known in which binding
of U1 snRNA to a 50 splice site is assisted by proteins belong-
ing to the SR protein family (5,11,20–23), we have recently
correlated the hydrogen bonding pattern of the RNA duplex
between U1 snRNA and the 50 splice site with U1 snRNA
binding (5,23). Using an HIV-1 glycoprotein expression
vector, we were able to develop an algorithm to describe
functional U1 snRNA binding sites (5) in the context of an
upstream bidirectional exonic splicing enhancer (23). Because
the overall strength of the hydrogen bonding between U1
snRNA and the 50 splice site correlated with glycoprotein
expression only as long as glycoprotein expression was sub-
optimal (11), we hypothesized that maximum stabilization of
the unstable glycoprotein pre-mRNA could be achieved with a
subset of the potential complementarity between the 50 splice
site and U1 snRNA. To address the question whether full
complementarity would result in hyperstabilization of
U1 snRNA binding in higher eukaryotes, thus blocking efﬁ-
cient usage of the 50 splice site and preventing the replacement
of U1 by U6 snRNA, we carried out a series of in vitro and
in vivo experiments.
Here, we investigated whether hyperstabilization of the
U1/50 splice site interaction interferes with the splicing efﬁ-
ciency inhuman celllines or nuclear extracts.In contrasttothe
phenomenaobserved inSaccharomyces cerevisiae,ourstudies
show that an extended U1 snRNA/50 splice site interaction did
not decrease splicing efﬁciency, but rather improved efﬁci-
ency and increased 50 splice site recognition. However, low
complementarity increased exon skipping and mRNA
degradation. Furthermore, an increase in the potential base
pairing interaction between U6 snRNA and the 50 splice
site did not appear to signiﬁcantly inﬂuence exon recognition.
MATERIALS AND METHODS
Oligonucleotides
Oligonucleotides were synthesized and puriﬁed as descri-
bed previously (24). The oligonucleotides are as follows:
814, 50-CATCAAGCTTCTCTATCAAAGCAGTACGTAT-
TACATGTAATGCA; 1084, CATCCTTAAGCTTCTCTATC-
TATCAGGTAAGTATTACATGTAATGCA; 1119, 50-CGG-
GGTAACATCC; 1120, 50-TTAAGGATGTTACCCCGAG-
CT; 1142, 50-TTAAGGATGCTACCTCGAGCT; 1143, 50-
CGAGGTAGCATCC; 1224, 50-TCTTCCAGCCTCCCATC-
AGCGTTTGG; 1225, 50-CAACAGAAATCCAACCTAGA-
GCTGCT; 1542, 50-CACCTTCTTCTTCTATTCCTT; 1544,
50-CTTGAAAGCGAAAGTAAAGC; 1834,50-CGAGAGCT-
CATCAGAACAGTCAGACTCATCAAGCTGCTCTATCA-
AAGCAGTAACACGTACATGTAATG; 1979, 50-CCAGG-
TTCTACAC; 1980, 50-TTAAGTGTAGAACCTGGAGCT;
1981, 50-CCAGGTAAGTAGC; 1982, 50-TTAAGCTACT-
TACCTGGAGCT.
Recombinant plasmids
The SV40 early env expression vector SV E/X tat
 rev
  car-
rying the EcoRI–XhoI fragment of pNLA1 (25) and the
50 splice site mutations were constructed as described previ-
ously (11). SVcrev was constructed by recloning the EcoRI–
XhoI fragment of pUHcrev (26) into pSVT7. Env expression
vector SV-env/GAR and the 50 splice site mutations were
constructed as described previously (23). All PCR-ampliﬁed
sequences were conﬁrmed by DNA sequencing. The
sequences of all constructs are available on request.
Cell culture and transfection
HeLa-T4
+ cells (27) were propagated and transfected as
described previously (11) with FuGENE 6 (Roche Molecular
Biochemicals), and the transfection efﬁciency was monitored
by cotransfection of pGL3-control (Promega). The medium
was changed after 24 h, and cells were harvested and prepared
48 h after transfection. For RT–PCR, cells were transfected
with 1 mg of the respective SV-1-env plasmid and 1 mgo f
pXGH5 (28) as a control for transfection efﬁciency, and total
RNA was isolated after 30 h.
Western blot analysis
Cells were scraped from six-well plates into the medium,
sedimented at 12000 g for 14 s, washed twice in
phosphate-buffered saline (PBS) and suspended in 200 ml
of SDS–PAGE sample buffer (29). An aliquot from the
PBS washing step was analyzed for luciferase activity
(luciferase assay system; Promega). The protein concentration
was measured by a Bradford protein assay (Bio-Rad) and
adjusted in each sample to equal amounts of luciferase activity
and protein amount by adding extracts of mock-transfected
cells. Samples were subjected to electrophoresis on SDS–7%
polyacrylamide gels and transferred to a polyvinylidene
diﬂuoride membrane (0.45 mm pore size, Immobillon  P;
Millipore). Protein detection was performed with a mono-
clonal mouse anti-gp120 antibody and visualized by a chemi-
luminescence detection system [ECL system and ECL
hyperﬁlm (Amersham)].
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Isolation of total RNA was performed using a modiﬁed guani-
dinium isothiocyanate protocol (30). Cells were washed twice
with 2 ml of PBS and cell lysis was performed with 500 mlo f
buffer D [7.6 ml of 2-mercaptoethanol, 50 ml of 3 M sodium
acetate (pH 4)], 500 ml of phenol and 100 ml of a chloroform-
isoamyl alcohol mixture (24:1) were added and mixed for 15 s.
After incubation on ice for 15 min, phases were separated by
centrifugation (10000 r.p.m., Eppendorf centrifuge). RNA
was precipitated in 1 vol of isopropanol overnight. After cen-
trifugation (10000 r.p.m., Eppendorf centrifuge) was washed
twice with 70% ethanol and dissolved in 10 ml of DMDC-
ddH2O. Prior to RT, 4 ml of RNA samples were subjected to
DNase I digestion using 10 U DNase I (Roche Molecular
Biochemicals) with 50 mM Tris, pH 7.5 and 10 mM MgCl2
in a total volume of 10 ml at room temperature for 1.45 h. After
DNase I inactivation at 95 C for 10 min, 4.5 ml of the DNase
digested RNA samples were reversed transcribed with 200 U
SuperScript III RNase H-Reverse Transcriptase (Invitrogen)
according to the manufacturer’s protocol using 0.375 mM
oligo(dT)15 (Roche Molecular Biochemicals) as primer.
PCR was carried out with 1.25 U AmpliTaq (Applied Biosys-
tems) in a total of 50 ml according to the manufacturer’s pro-
tocol in a Robocycler Gradient 96 Temperature Cycler
(Stratagene). All primers were used at a ﬁnal concentration
of 0.2 mM. Double-spliced and skipped RNA was detected
with primer pair 1544/1542. PCR products were separated
on 6% non-denaturing polyacrylamide gels, stained with
ethidium bromide for 10 min and visualized with the Lumi-
Imager F1 (Roche Molecular Biochemicals). For the detection
of hGH mRNA in the RT–PCR assay primer pair 1225/1224
was used.
In vitro splicing
Reactions were carried out in 30% nuclear extract, containing
T7 generated
32P-labeled RNA transcripts, 1.0 mM ATP,
20 mM creatine phosphate, 3.2 mM MgCl2 and incubated
at 30 C for a determined time course indicated in ﬁgure leg-
ends. Following incubation, reactions were proteinase K
digested, phenol–chloroform extracted, ethanol precipitated,
resolved on 8% denaturing PAGE and measured by Phospho-
rImager analysis (Bio-Rad) as described previously (31).
Percent spliced is deﬁned as spliced product/(unspliced
product + spliced product). To derive kinetic rate constants,
time points were ﬁt to a ﬁrst order rate description for product
appearance. Rates of degradation were computed by ﬁtting the
total counts per lane to a ﬁrst order decay rate description.
Prior to ﬁtting, the counts detected in each lane were normal-
ized to input (loading volume). The background was deter-
mined individually for each lane, as the total number of
substrate and product counts varied throughout the time
course. Rate determinations were repeated at least three times.
RNAs used for in vitro splicing
DNA templates encoding regions of the ﬁrst two exons
(excluding the 50 splice site of exon 2) of b-globin were cloned
downstream of the T7 promoter in the SP73 plasmid. Alter-
native 50 splice site cassettes were cloned into the location of
the original 50 splice site of exon 1, and potential cryptic 50
splice sites (those containing a GT) were mutated within the
exonic and intronic regions surrounding the 50 splice site
of exon 1. These b-globin minigenes were subsequently
linearized.
32P-labeled RNA transcripts were synthesized
by T7 RNA polymerase and resolved and puriﬁed on 4%
denaturing PAGE.
RESULTS
Hyperstabilization of the U1 snRNA/50 splice site
interaction maintains efficient splicing and
promotes RNA stability
To determine how the efﬁciency of pre-mRNA splicing is
inﬂuenced by hyper- and hypostabilization of the RNA duplex
formed between U1 snRNA and the 50 splice site, we have
made use of HIV-1 env expression vectors. In the absence of
the viral regulatory protein Rev these vectors are one-intron
splicing reporters (Figure 1A). We performed splicing assays
for a series of 50 splice sites with increasing complementary
with U1 snRNA (Figure 1B). Following transient transfection
of HeLa-T4
+ cells, we detected measurable levels of spliced
mRNAs only for the substrates with 50 splice sites that can
form 14 or more hydrogen bonds with U1 snRNA (Figure 1C,
lanes 2–5, 9 and 10), but not with fewer (Figure 1C, lane 1).
Figure 1. Full complementarity between the 50 splice site and U1 snRNA
maintains efficient splicing and RNA stability. (A) Schematic drawing of
the HIV-1 pre-mRNA transcripts synthesized from env expression vectors.
(B) Sequences of the 50 splice sites analyzed. Mismatches to U1 snRNA are
given in lower case letters. Possible H-bonds (U1 H-bond) and ‘HC’/‘LC’
classification were calculated using the splicefinder algorithm (www.
splicefinder.net) (5). (C) RT–PCR assay (upper panel) and immunoblot
analysis of glycoproteins (lower panel) of HeLa-T4
+ cells transfected with
envexpressionvectorscarryingmutationsintheSD450 splicesiteandpXGH5
expressingthehGHmRNAasaninternalcontrol.Fortheimmunoblotanalysis
SVcrev and pGL3-control instead of pXGH5 was cotransfected as described
previously (5). The numbers above each lane indicate the 50 splice site tested;
each lane is numbered below the image.
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with U1 snRNA (11 bp, 24 hydrogen bonds) were spliced
as efﬁciently as any other pre-mRNA with fewer base pair
interactions. Because the splicing analyses were carried
out within the linear range of ampliﬁcation for the viral tem-
plate, we conclude that hyperstabilization of the U1 snRNA
interaction with the 50 splice site does not lead to reduced
efﬁciency of pre-mRNA splicing under the conditions
used here.
To investigate whether the lack of detection of spliced
mRNA (Figure 1C, lane 1) was independent of the position
of the formed RNA duplex, we analyzed additional 50 splice
site mutations that differed in the position of their continuous
stretch of complementary nucleotides while maintaining 12
possible hydrogen bonds (Figure 1C, lane 6–8). Even though
computational predictions of these 50 splice sites suggested
signiﬁcant differences in intrinsic strength [the MaxEntScore
of these four 50 splice site varies from 0.74 to 4.95 (32)], none
of them allowed detection of spliced mRNA. These results
suggest that irrespective of the predicted duplex strength, a U1
snRNA/50 splice site interaction formed by only 12 hydrogen
bonds is too low to form a stable RNA duplex that initiates
pre-mRNA splicing.
We have demonstrated previously that in the presence of
Revthestability oftheunsplicedenvmRNA dependscritically
on the hydrogen bonding pattern between the 50 splice site and
U1 snRNA (11). Hence, HIV-1 env gene expression allows
monitoring U1 snRNA binding at the 50 splice site. Therefore,
we repeated the transfection experiments with cotransfection
of a Rev expression vector and analyzed glycoprotein expres-
sion. In agreement with the results obtained by RT–PCR,
western blot analysis of cells transfected with constructs
capable of forming more than 12 consecutive hydrogen
bonds with U1 snRNA showed wild-type env expression
levels (Figure 1C, lower panel, lane 2–5, 9 and 10). We
conclude that at least 14 hydrogen bonds are required to
stabilize env RNA levels and that hyperstabilization of this
interaction does not limit env protein expression.
Hyperstabilization of the U1 snRNA/50 splice site
interaction does not cause an inhibition of
exon recognition
To examine how exon recognition is inﬂuenced by stabilizing
the U1 snRNA/50 splice site interaction in pre-mRNA sub-
strates containing multiple exons, we enlarged the HIV-1 tran-
scription unit to obtain a 2-intron HIV-1 sub-genomic env
expression construct (Figure 2A). The 50 splice site of the
internal exon was varied as shown in Figure 2B. The splicing
patterns of these constructs were analyzed using RT–PCR
within the linear range of ampliﬁcation for the viral template
(Figure 2D, upper panel) and with an hGH substrate as a
loading control (Figure 2D, lower panel). Identiﬁcation of
the splice junctions was obtained by sequence analysis of
gel-isolated PCR fragments. More than 12 hydrogen bonds
or 5 consecutive base pairs between the 50 splice site and
U1 snRNA resulted in exclusive inclusion of the internal
exon (Figure 2D, lanes 3 and 4). As was observed for the
single exon substrate, hyperstabilization of the U1 snRNA/
50 splice site interaction did not cause an inhibition of exon
recognition or exclusion. However, reduced complementarity
resulted in exon skipping (Figure 2D, lane 2), demonstrating
that the recognition of the internal exon is a stochastic process
(Figure 2D, lanes 1 and 2). We conclude that hyperstabiliza-
tion of the interaction between U1 snRNA and the 50 splice site
favors exon inclusion without reducing the efﬁciency of the
splicing reaction.
To assess whether the relative competition between the
mutually exclusive interactions of either U1 snRNA with
the 50 splice site or U6 snRNA with the 50 splice site inﬂuences
pre-mRNA splicing patterns, additional two-intron test sub-
strates were evaluated for splicing efﬁciency and RNA stabil-
ity. Increasing the base pairing between U6 snRNA and the
test 50 splice site from 5 to 6 bp (from 11 to 13 hydrogen
bonds), while maintaining the strength of the U1 snRNA/50
splice site interaction (compare Figure 2B, #11 and #12, and
Figure 2C), did not generate detectable changes in the levels of
exon inclusion (Figure 2D, compare lane 5 with lane 6) or of
the stability of the unspliced env mRNA (data not shown).
Figure 2. Fullcomplementarity betweenthe 50 splicesite andU1 snRNAdoes
not compromise internal exon inclusion. (A) Schematic drawing of the three-
exon substrates used. Each substrate contains the HIV-1 genome but lacks the
U3 region of the 50 LTR, the non-coding region of the 30 LTR and the region
downstream of the gag start codon, as described previously (5). The asterisk
indicates the alternative 30 splice site SA4a. (B) Sequences of the analyzed 50
splice sites. Mismatches to U1 snRNA are given in lower case letters. Possible
H-bondsbetweenthe50 splicesiteandU1snRNA(U1H-bond)andU6snRNA
(U6H-bond)areindicated.‘HC’/‘LC’classificationswerecalculatedusingthe
splicefinder algorithm (www.splicefinder.net) (5). (C)5 0 splice site sequences
for substrates#6, #11 and #12.All possiblebase pairs withU1 snRNA(above)
and U6 snRNA (below) are shown. Mismatches to U1 snRNA are given in
lower case letters. (D) RT–PCR assay of HeLa-T4
+ cells transfected with the
test 50 splice sites and with pXGH5 expressing the hGH mRNA as an internal
control.Thenumbersaboveeachlaneindicatethe50 splicesitetested;eachlane
is numbered below the image. The numbers to the left of the image define the
sizes of DNA markers. The cartoon on the right of the image defines the
migration of exon included- and exon excluded spliced products. The asterisk
indicates an alternative exon inclusion product using the alternative 30 splice
site SA4a. All spliced products were verified by sequence analysis.
Nucleic Acids Research, 2005, Vol. 33, No. 16 5115We conclude that the degree of U6 snRNA interaction with the
50 splice site does not signiﬁcantly inﬂuence the observed
splicing patterns.
Extended base pairing between U1 snRNA and
the 50 splice does not lead to inhibition of
pre-mRNA splicing in vitro
Hyperstabilization of the interaction between U1 snRNA and
the 50 splice site in yeast was observed to be strikingly
inhibitorywhenassayedatlower temperatures(9).Toevaluate
the effects that extended base pairing between U1 snRNA and
the 50 splice site has on pre-mRNA splicing at different tem-
peratures an in vitro splicing assay was used. Test pre-mRNAs
containing variable 50 splice sites were assayed at different
reaction temperatures in HeLa cell nuclear extract to evaluate
their kinetics of splicing. As illustrated in Figure 3 and sum-
marized in Table 1, pre-mRNAs containing 50 splice sites with
extended U1 snRNA base pairing were active at the highest
and lowest temperatures tested. In contrast, pre-mRNAs con-
taining reduced U1 snRNA base pairing were active only at
lower temperatures. At the highest temperature tested (37 C),
theefﬁciencyofpre-mRNAsplicingwasreducedsigniﬁcantly.
Furthermore, the data summarized in Table 1 support the
above conclusion that the magnitude of U6 snRNA interaction
with the 50 splice site does not inﬂuence the efﬁciency of
splicing in the context of the pre-mRNAs tested. While the
complementarity between the 50 splice site and U1 snRNA
signiﬁcantly inﬂuenced the steady-state levels of the test sub-
strate (Figure 3), the in vitro splicing analysis detected only
minordifferencesinthestability ofthetestRNA.Weconclude
that extended base pairing between U1 snRNA and the
50 splice does not lead to inhibition of pre-mRNA splicing,
even at the lowest temperature tested (21 C).
DISCUSSION
The analysis presented here does not support the notion that
increased complementarity between the 50 splice site and U1
snRNA is inhibitory to pre-mRNA splicing in mammalian cell
culture or in vitro splicing assays. Rather, extended base pair
interactions with U1 snRNA led to increased exon inclusion,
higher efﬁciencies of pre-mRNA splicing and greater overall
Figure 3. Invitrosplicingefficiencyofpre-mRNAswithhyper-andhypostabilizedinteractionwithU1snRNA.Representativereactionprofilesareshownforpre-
mRNAs with an extended U1 snRNA interaction potential (A) and a pre-mRNA with a low U1 snRNA interaction potential (B). Each time course was used to
determineobserved ratesofsplicingateach temperature tested.The averagerateofsplicingis shownbelow each timecourse.Rate determinations wererepeatedat
least three times. The nucleotide sequence above each autoradiogram represents the 50 splice site sequences of the test pre-mRNA. Capital letters symbolize base
pairing with U1 snRNA; small letters symbolize mismatched nucleotides with U1 snRNA. The vertical line (|) indicates the intron/exon junction. The identities of
spliced and unspliced RNAs are indicated on the right.
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with a recent analysis of cryptic splice site activation,
which demonstrated that the complementarity of the 50 splice
site to the 50 end ofthe U1 snRNA was the dominant parameter
in determining the extent of splicing at the aberrantly activated
50 splice site (33). However, 50 splice site recognition is also
inﬂuenced by the activities of protein components within
U1 snRNP, as demonstrated by functional SELEX experi-
ments in the absence of the 50 end of U1 snRNA (34–37).
It was suggested that other factors such as the U1 snRNP
speciﬁc protein U1-C contribute to sequence speciﬁcity. Simi-
larly, the U5 snRNP speciﬁc protein Prp8 is likely to stabilize
the interaction of U5 snRNA with the 50 splice site. These
proposals were supported by the observations that U1-C
(21,38) as well as Prp8 cross-link to the 50 splice site
(39–44). Despite these additional protein contributions to
the recognition of the 50 splice site, the dominance of the
RNA/RNA in the activation of the 50 splice site has been
shown unequivocally in many cases by restoring the function-
ality of mutated 50 splice sites in the presence of compensatory
changes in U1 snRNAs (5,11,45,46).
A survey of annotated 50 splice sites of human chromosome
6 revealed the presence of 0.1% naturally occurring 50 splice
sites with a perfect match to all 11 nt of the 50 end of U1
snRNA (H. Schaal, unpublished data). Interestingly, when
calculating the strength of all splice sites of a randomly chosen
gene, PLA2G7 [(platelet-activating factor (PAF) acetylhydro-
lase], we found that the constitutively spliced exons #2 and
#10 which carry the weakest 30 splice sites [MaxEntScore (32)
<5.0] are ﬂanked by 50 splice sites of higher-than-average
complementary (Figure 4). Although speculative, these obser-
vations suggest that highly complementary 50 splice sites
might compensate for weak upstream 30 splice sites to ensure
exon recognition in higher eukaryotes.
In agreement with previous studies (23), we show that
hypostabilized 50 splice sites are discriminated against. This
may be due to insufﬁcient binding of U1 snRNP to the 50 splice
site, thus resulting in reduced recognition of the 50 splice site
and, consequently, to higher frequencies of exon exclusion.
As expected from thermodynamic considerations for RNA
duplexes, the reduced recognition of a splice site with
decreased U1 snRNA complementarity could be overcome
by lowering the temperature to 30 C (Figure 3B). These
results are consistent with the temperature-dependent splicing
of human b-globin (47) and human collagen substrates (48),
where correct splicing could be restored by incubating cells
at decreased temperature.
The observation that an increased complementarity between
the 50 splice site and U1 snRNA is not inhibitory to pre-mRNA
splicing in higher eukaryotes, even at lower temperatures,
highlights that the replacement reaction of U1 snRNP with
U6snRNP duringspliceosomeactivationisanotherdistinction
between the splicing mechanisms employed by higher eukary-
otes and S.cerevisiae. In addition, we ﬁnd that unlike the
observation made in S.cerevisiae, the degree of U6 snRNA
interaction with the 50 splice site did not inﬂuence the splic-
ing patterns signiﬁcantly in the mammalian system analyzed
here. Increasing the base pairing between U6 snRNA and the
50 splice site, while maintaining the strength of the U1 snRNA/
50 splice siteinteraction,didnotgeneratedetectablechangesin
the levels of exon inclusion or splicing efﬁciency (Figure 2).
Comparable mutations, allowing additional base pair interac-
tions at position +4 of the 50 splice site, were also tested in a
human b-globin competition assay (33). In agreement with our
data, mutations that activated splicing at the cryptic 50 splice
site correlated with increased stability of the RNA duplex
between the 50 splice site and the U1 snRNA, regardless of
their level of complementarity toU6 snRNA (33). However, in
Table 1. Rates of splicing
a and degradation
a for pre-mRNA substrates with variable 50 splice site strengths
50 Splice site of substrate
b U1 Match
c U6 Match
c 21 C( h
 1)3 0  C( h
 1)3 7  C( h
 1) Ratio of 30 C/21 C Degradation 37 C( h
 1)
CAG|GUAAGUAg 23| k|2k7| 0.21 0.84 1.14 4 0.36
CAG|GUAAGUca 21kk |2k5k 0.34 1.26 0.31 4.75 1
CAG|GUugGUAU 12k8 k|3|9 0.3 0.78 0.036 2.6 0.72
CAG|GUucuaca 12kkk k|3kk| 0.12 0.42 0.015 3.5 0.6
gca|GUAcguau k|7|8 k|2k9 0.18 0.57 0.06 3.12 0.48
gca|GUAuguau k|7|8 k|2|11 0.12 0.42 0.016 3.5 0.54
aEach value was determined from at least two independent splicing reactions.Experimental error for each rate determinationis within 20%. Rates determined from
different experiments varied within 2-fold.
bTheverticalline(|)indicatestheintron/exonjunction.50 Splicesitesequencesarelistedfromthe 3tothe+8position.CapitalletterssymbolizebasepairingwithU1
snRNA; small letters symbolize mismatched nucleotides with U1 snRNA.
cThenumberofhydrogenbondsbetweenthe50 splicesitesandU1snRNAorU6snRNAwerecalculatedaccordingtoFreundetal.(5).Theverticallines(|)designatea
mismatched nucleotide position.
Figure 4. Schematic drawing of the exon–intron structure of PLA2G7 platelet-activating factor acetylhydrolase. H-bond patterns of the 50 splice sites calculated
according to the splicefinder algorithm (5) are shown above the exons (open boxes), the calculated strength of the 30 splice sites as MaxEntScores (32) below the
respective exons.
Nucleic Acids Research, 2005, Vol. 33, No. 16 5117a few reported cases U6 snRNA, rather than U1 snRNA,
seemed to direct the position of the 50 splice site. Nevertheless,
selection always depended on the vicinity of a U1 binding site
(49,50).
The observation that hyperstabilization of the U1 snRNA
interaction with the 50 splice site did not interfere with pre-
mRNA splicing efﬁciency demonstrates that the transition of
50 splice site interactions with U1 snRNP to interactions with
U6 snRNP within the mammalian spliceosome is not at risk of
being rate limiting. These considerations suggest that the heli-
case(s) catalyzing the U1/U6 transition is(are) substantially
more efﬁcient in executing its function when compared
with other RNA/RNA or RNA/protein rearrangements or cat-
alytic steps of the mammalian splicing reaction. The high
efﬁciency of the U1/U6 transition in mammals could be
explained by the involvement of more than one helicase par-
ticipating in the rearrangements at the 50 splice site. Indeed,
cross-linking experiments revealed an interaction of a 65 kDa
protein (p65) with the U1/50 splice site RNA duplex during
spliceosome assembly (51). This p65 protein was later iden-
tiﬁed as the essential p68 RNA helicase (52). Depletion of
endogenous p68 RNA helicase in HeLa nuclear extracts did
not affect the binding of U1 snRNP to the 50 splice site,
whereas dissociation of U1 snRNP from the 50 splice site
was largely inhibited (52). These data suggested that at
least two RNA helicases (U5-100k, p68) function in destabi-
lizing the U1 snRNA/50 splice site interaction in the mamma-
lian splicing reaction. Thus, it is possible that the involvement
of multiple helicases could explain why the mammalian U1/
U6 transition of hyperstabilized 50 splice sites appears to be
more efﬁcient than the yeast counterpart.
Furthermore, Chen and co-workers (53) have shown that
speciﬁc mutations that alter the U1 associated protein U1-C
can bypass the requirements for Prp28p during the U1/U6
transition. These results suggest that Prp28p counteracts the
stabilizing effects of U1-C on the U1/50 splice site RNA
duplex (53) rather than disrupting the base pairs between
U1 snRNA and the 50 splice site. In mammalian cells, it is
possible that p68 and U5-100K cooperate in destabilizing the
interaction between U1 snRNP and the 50 splice site, one
acting on the protein factors and the other acting directly
on the RNA duplex.
S.cerevisiae contains relatively few intron-containing
genes. It is possible that yeast may have evolved a less ﬂexible
and smaller range of variance in the 50 splice site nucleotide
sequence to optimize its initial recognition by U1 snRNP and
the subsequent replacement by U6 snRNP. In mammals, the
kinetics at this rearrangement step is not rate limiting, thus
permitting a greater deviation in recognizable 50 splice site
signals, from weak to strong (according to U1 snRNA bind-
ing). In turn, this relaxation may permit a greater range of
potential 50 splice sites, ultimately resulting in more alter-
native 50 splice site splicing patterns and increased proteomic
divergence.
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